Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

View:
Post by tankumo on Oct 05, 2023 8:33pm

covid

Covid is coming back big time, I hope DM will get new test kit contracts!!!!  https://theprovince.com/news/local-news/covid-19-bc-hospitalizations-up-infections-deaths-spike/wcm/279625ce-8640-4948-a2ae-b4e06d10a18b
Comment by scottrose on Oct 06, 2023 8:01am
Returning to COVID is not the way forward. The company should keep its main focus on AI, which has a more long-term perspective. Analytics is a scalable platform, Nexa can still secure those contracts, and EV can continue to generate marginal revenues. Reverting to COVID kits should not be the path forward; instead, they just need to replicate the success of the kits with AI.
Comment by Shlinker_ on Oct 06, 2023 8:25am
I don't see anyone suggesting a return to covid testing would replace the other verticals. I suspect a return to covid testing would be an amazing way to fund the verticals moving forward. The company does after all have a medical division (as small as that may be). I think DM likely releases a NR stating they are starting testing up again for some TV/Film industry partners. I give it less ...more  
Comment by MarketMaestro on Oct 06, 2023 9:04am
I agree, such a scenario would certainly solve their cashflow issues and give help fund their other activities.
Comment by scottrose on Oct 06, 2023 9:57am
The medical division is in the process of being spun out, with the major reason being the desire to shift focus towards AI and EV. While they might consider returning to the COVID path, I believe that concentrating al their efforts on AI is the best way to maximize returns from this high-potential vertical.
Comment by Aiking on Oct 06, 2023 11:24am
Exactly Scottrose, DM has the highest chance to to successful in Ai, if they focus on it. Also that's the technology investors like. It's Ai time on Wallstreet.
Comment by Aiking on Oct 06, 2023 8:33am
COVID won't be the big thing this year, simply because the WHO says. There is no WHO alarming signal. WHO covid communication is appeasing. https://www.who.int/publications/m/item/covid-19-epidemiological-update---29-september-2023 All the numbers are decreasing and the WHO reports aren't published every week anymore, but only every four weeks. Ai is DM future! Stick to it!
Comment by dirtydzn on Oct 06, 2023 8:50am
How much will that cost to start it back up? Considering we just spent a bunch closing it down as per MG and our terrible financials last quarter. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities